Physician profile
Michael P Della Corte
NPI 1205812146
$5,969.30
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,547 · 2020: $183 · 2021: $112 · 2022: $127.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Royal Biologics, INC. | $4,496.11 | 2019-2020 | |
| Stability Biologics, LLC | $239.29 | 2021-2022 | |
| Orthofix Medical, INC. | $212.70 | 2019 | |
| Baxter Healthcare | $212.46 | 2019 | |
| Integra Lifesciences Corporation | $162.49 | 2019 | |
| Organogenesis INC. | $148.54 | 2019 | |
| Stryker Corporation | $114.93 | 2019 | |
| Medline Industries LP | $91.30 | 2019 | |
| Axogen | $70.62 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $64.81 | 2019 | |
| Advanced Oxygen Therapy INC. | $48.58 | 2019 | |
| Derma Sciences, INC. | $29.67 | 2019 | |
| Smith+Nephew, INC. | $29.37 | 2019 | |
| Wright Medical Technology, INC. | $23.02 | 2019 | |
| Allergan, INC. | $12.85 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $12.56 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Della Corte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.